BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB
35 results:

  • 1. Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Peng Y; Huang J; Yin J; Meng F; Cao Y; Huang L; Li D; Zhang Y; Zhang D; Meng L; Han Z; Hong Z
    Expert Rev Hematol; 2024; 17(4-5):173-180. PubMed ID: 38616308
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis.
    Włodarczyk M; Wieczorkiewicz-Kabut A; Białas K; Koclęga A; Noster I; Zielińska P; Helbig G
    Turk J Haematol; 2024 Mar; 41(1):9-15. PubMed ID: 38345092
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.
    Tomasulo E; Paul S; Mu R; Tian X; Chen J; Pleyer C; Wiestner A; Sun C
    Leuk Lymphoma; 2023 Dec; 64(14):2306-2315. PubMed ID: 37732614
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive analysis of ercc3 prognosis value and ceRNA network in AML.
    Bao X; Chen Y; Lou X; Du J; Li H; Liu N; Tang Z; Hua J; Guo W; Liu SB
    Clin Transl Oncol; 2023 Apr; 25(4):1053-1066. PubMed ID: 36472749
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigations of methods for multiple time-to-event endpoints: A chronic myeloid leukemia data analysis.
    Wu H; Hou Y; Chen Z
    J Eval Clin Pract; 2023 Feb; 29(1):211-217. PubMed ID: 35945813
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
    Chevallier P; Berceanu A; Peterlin P; Garnier A; Le Bourgeois A; Imbert BM; Daguindau E; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Tessoulin B; Vantyghem S; Desbrosses Y; Bressollette C; Duquesne A; Eveillard M; Le Bris Y; Dormoy A; Malugani C; Deconinck E; Moreau P; Le Gouill S; Béné MC; Guillaume T
    Acta Oncol; 2021 Apr; 60(4):466-474. PubMed ID: 33112687
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CDK9: a signaling hub for transcriptional control.
    Bacon CW; D'Orso I
    Transcription; 2019 Apr; 10(2):57-75. PubMed ID: 30227759
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nucleotide excision repair is a potential therapeutic target in multiple myeloma.
    Szalat R; Samur MK; Fulciniti M; Lopez M; Nanjappa P; Cleynen A; Wen K; Kumar S; Perini T; Calkins AS; Reznichenko E; Chauhan D; Tai YT; Shammas MA; Anderson KC; Fermand JP; Arnulf B; Avet-Loiseau H; Lazaro JB; Munshi NC
    Leukemia; 2018 Jan; 32(1):111-119. PubMed ID: 28588253
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
    Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ELL, a novel tfiih partner, is involved in transcription restart after DNA repair.
    Mourgues S; Gautier V; Lagarou A; Bordier C; Mourcet A; Slingerland J; Kaddoum L; Coin F; Vermeulen W; Gonzales de Peredo A; Monsarrat B; Mari PO; Giglia-Mari G
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17927-32. PubMed ID: 24127601
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ercc3 and hematotoxicity in benzene-exposed workers.
    Xing C; Chen Q; Li G; Zhang L; Zheng M; Zou Z; Hou L; Wang QF; Liu X; Guo X
    Environ Mol Mutagen; 2013 Jul; 54(6):397-405. PubMed ID: 23797950
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The lost intrinsic fragmentation of MAT1 protein during granulopoiesis promotes the growth and metastasis of leukemic myeloblasts.
    Lou S; Liu G; Shimada H; Yang X; He Q; Wu L
    Stem Cells; 2013 Sep; 31(9):1942-53. PubMed ID: 23765726
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Correlation between level of metallic elements in urine and childhood acute leukemia].
    Zhu S; Zhang Y; Gao Y; Wang XJ; Chen T; Yang Y; Shi R; Jin P; Tian Y; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Feb; 45(2):146-9. PubMed ID: 21426795
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. xpb mediated retroviral cDNA degradation coincides with entry to the nucleus.
    Yoder KE; Roddick W; Hoellerbauer P; Fishel R
    Virology; 2011 Feb; 410(2):291-8. PubMed ID: 21167544
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.
    Kruse U; Pallasch CP; Bantscheff M; Eberhard D; Frenzel L; Ghidelli S; Maier SK; Werner T; Wendtner CM; Drewes G
    Leukemia; 2011 Jan; 25(1):89-100. PubMed ID: 20944678
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association between genetic variants in VEGF, ercc3 and occupational benzene haematotoxicity.
    Hosgood HD; Zhang L; Shen M; Berndt SI; Vermeulen R; Li G; Yin S; Yeager M; Yuenger J; Rothman N; Chanock S; Smith M; Lan Q
    Occup Environ Med; 2009 Dec; 66(12):848-53. PubMed ID: 19773279
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cells.
    Laurenzana A; Petruccelli LA; Pettersson F; Figueroa ME; Melnick A; Baldwin AS; Paoletti F; Miller WH
    Cancer Res; 2009 Jan; 69(1):55-64. PubMed ID: 19117987
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia.
    Mosor M; Ziółkowska I; Januszkiewicz-Lewandowska D; Nowak J
    Eur J Cancer; 2008 Oct; 44(15):2226-32. PubMed ID: 18691878
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter.
    Witcher M; Pettersson F; Dupéré-Richer D; Padovani A; Summers-Deluca L; Baldwin AS; Miller WH
    Nucleic Acids Res; 2008 Feb; 36(2):435-43. PubMed ID: 18039708
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.